Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Superior vena cava obstruction

Oncology and palliative care · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Airway or cerebral compromise from SVCO

Stridor, laryngeal oedema, severe respiratory distress, syncope, confusion, reduced consciousness or rapidly progressive head and neck swelling indicates high-risk superior vena cava obstruction.

Action: Sit the patient upright, use ABCDE assessment and monitoring, secure senior airway, acute-oncology and interventional-radiology help, obtain urgent contrast-enhanced imaging if physiology permits and prioritise endovascular decompression when life-threatening obstruction cannot wait for tissue-directed therapy.

Synopsis

Recognise impaired upper-body venous drainage, distinguish airway or cerebral danger from stable obstruction, define malignant and thrombotic anatomy, obtain tissue safely and select stenting, anticoagulation or tumour-directed treatment.

  • SVCO causes facial, neck and arm swelling, venous distension, breathlessness, cough and head pressure that often worsens when lying flat or bending forward.
  • Airway oedema, stridor, severe respiratory distress, confusion or reduced consciousness defines a decompression emergency; sit upright and involve airway and interventional teams immediately.
  • First-line anatomical investigation in a stable patient is contrast-enhanced CT of chest and central veins, which shows level, length, collaterals, thrombus, tumour and a tissue target.
  • Obtain histology before radiotherapy or systemic treatment when the patient is stable and no prior diagnosis exists, because lymphoma, small-cell lung cancer and other causes require different treatment.
  • Endovascular stenting provides the fastest reliable symptom relief and is preferred for severe or rapidly progressive obstruction, particularly when tissue diagnosis or tumour response will take time.
  • Anticoagulate confirmed catheter-associated or bland thrombosis when bleeding risk allows; decide line retention, removal and thrombectomy with oncology, haematology and interventional radiology.
  • Use tumour-directed chemotherapy or radiotherapy for durable control according to histology and stage; neither should be given empirically to every undiagnosed mediastinal mass.
  • Corticosteroids are not routine mechanical decompression and can obscure lymphoma histology; reserve them for a specific steroid-responsive tumour or associated airway or cerebral oedema after specialist discussion.

Key red flags

Stridor, voice change, drooling, severe orthopnoea or facial and tongue oedema raises impending upper-airway compromise.

Confusion, agitation, severe headache, visual change, syncope or reduced consciousness suggests critical cerebral venous congestion or another neurological emergency.

Rapid symptom progression over hours or inability to lie flat requires monitored assessment and urgent decompression discussion.

Unilateral arm swelling, catheter dysfunction or neck and chest-wall collaterals may indicate device-associated thrombosis extending into the caval system.

Haemodynamic collapse is unusual in isolated SVCO and should prompt simultaneous assessment for tamponade, pulmonary embolism, tension pneumothorax and sepsis.

Airway danger

Voice change, dysphagia, stridor, tongue swelling, orthopnoea or rapidly increasing neck oedema requires senior airway and decompression planning.

Cerebral venous danger

Severe headache, visual obscuration, confusion, syncope, seizure or reduced consciousness suggests critical cranial venous pressure.

Investigation priorities

01
First-line contrast-enhanced CT chest and central veinsFirst stepFirst line

Map obstruction, thrombus, collaterals and tumour and identify a biopsy route and other thoracic emergencies.

Management branches

TriageIdentify airway and cerebral danger

Facial or upper-limb swelling and venous distension suggest central thoracic venous obstruction.

  1. Sit the patient upright, assess airway voice and stridor, breathing, circulation and cognition and establish monitoring and intravenous access outside a severely congested limb where possible.
  2. Call acute oncology and interventional radiology urgently; involve anaesthesia or critical care immediately for airway swelling, severe orthopnoea, syncope or neurological change.
  3. Obtain contrast-enhanced CT urgently if physiology allows, but do not make an unstable airway wait for a complete elective tissue sequence before decompression planning.
Stable undiagnosedSecure tissue before tumour therapy

The patient is physiologically stable and imaging shows a mediastinal tumour without established histology.

  1. Select the safest high-yield biopsy route with radiology, respiratory, haematology or surgery, preserving architecture and molecular material.
  2. Avoid empirical radiotherapy or corticosteroid exposure that may erase diagnostic lymphoma tissue unless a senior risk-benefit decision documents an urgent indication.
  3. Stage and treat the confirmed tumour with the relevant MDT, using chemotherapy, radiotherapy, immunotherapy or combined care according to biology and goals.

Key medicines

Therapeutic anticoagulationUse the current cancer-associated thrombosis regimen at treatment dose, such as weight-based low-molecular-weight heparin or an appropriate direct oral anticoagulant, adjusted for renal function, platelets, bleeding site, interactions and planned biopsy or stenting.Luminal gastrointestinal or genitourinary tumour, intracranial disease, thrombocytopenia, renal failure and urgent procedures alter choice and timing; anticoagulation cannot mechanically relieve fixed external compression.
Dexamethasone in selected oedema or steroid-responsive tumourUse only the acute-oncology or lymphoma-specific specialist regimen when associated airway or cerebral oedema or a confirmed steroid-responsive tumour justifies it; there is no routine dose for all mechanical SVCO.Steroids do not open a fixed caval obstruction and can compromise lymphoma diagnosis. Monitor glucose, infection, delirium and gastrointestinal risk and obtain tissue first whenever stable enough.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • UKONS acute oncology initial management guidelinesUK recognition, severity assessment and immediate SVCO management framework.
  • NICE NG158 venous thromboembolic diseasesDiagnosis and anticoagulation principles for venous thrombosis and cancer.
  • CIRSE vena cava stenting informationEndovascular venography, central venous stenting and procedural risk context.
  • NICE NG12 lung and mediastinal cancer referralUrgent investigation and tissue pathways for thoracic malignancy.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom